Imax Corp. buy Traumtanz
Start price
15.02.25
/
50%
€25.60
Target price
15.02.26
€27.00
Performance (%)
-17.97%
End price
29.04.25
€21.00
Summary
This prediction ended on 29.04.25 with a price of €21.00. The price of Imax Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -17.97%. Traumtanz has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Imax Corp. | 5.882% | 5.882% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to Traumtanz what are the pros and cons of Imax Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Medium risks for its business
Stable Large shareholder and/or long term investor
Growths faster than the competition
Capable Management
Sustainability is important
Differentiated customer and product portfolio
Good culture
Innovative
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Cons
Comments by Traumtanz for this prediction
In the thread Imax Corp. diskutieren
Buy mit Kursziel 27,0
In the thread Trading Imax Corp.
Buy beendet
Stopped prediction by Traumtanz for Imax Corp.
Imax Corp.
Start price
Target price
Perf. (%)
€24.40
11.02.25
11.02.25
€26.00
11.02.26
11.02.26
4.10%
14.02.25
14.02.25
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
